Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Sales/Fixed Asset

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Sales/Fixed Asset(x) 1.041.061.551.662.51

What is the latest Sales/Fixed Asset ratio of GLAND PHARMA ?

The latest Sales/Fixed Asset ratio of GLAND PHARMA is 1.04 based on Mar2026 Consolidated results.
Year Sales/Fixed Asset
Mar20261.04
Mar20251.06
Mar20241.55
Mar20231.66
Mar20222.51

How is Sales/Fixed Asset of GLAND PHARMA Trending?

Years Sales/Fixed Asset % Change
Mar2026 1.04
-1.89
Mar2025 1.06
-31.61
Mar2024 1.55
-6.63
Mar2023 1.66
-33.86
Mar2022 2.51 -

Other Financial Ratios of GLAND PHARMA


Compare Sales/Fixed Asset ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹48,537.2 Cr 2.1% 4.2% 47% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,196.0 Cr 1.8% -1.7% 14.6% Stock Analytics
DIVIS LABORATORIES ₹250,390.0 Cr 2.6% 9.8% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,967.0 Cr 2.4% -0.5% 36% Stock Analytics
CIPLA ₹111,888.0 Cr 1.8% -3.7% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹100,329.0 Cr 4.5% 1.8% -10% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.1%

4.2%

47%

SENSEX

0.1%

-2.7%

-8.6%


You may also like the below Video Courses